These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1078960)

  • 1. [Investigations on the effectiveness of a new antimycotic through experimental keratomycosis in rabbits (author's transl)].
    Oggel K; de Decker W
    Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1975; 193(3):189-92. PubMed ID: 1078960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the activity of a new antimycotic (Bay b 5097) in children.
    Weingärtner L; Sitka U; Patsch R; Gründig C
    Int J Clin Pharmacol; 1972 Nov; 6(4):358-63. PubMed ID: 4641850
    [No Abstract]   [Full Text] [Related]  

  • 3. Orally administered antifungal therapy for experimental keratomycosis.
    O'Day DM
    Trans Am Ophthalmol Soc; 1990; 88():685-725. PubMed ID: 2095036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bay B 5097, a new orally applicable antifungal substance with broadspectrum activity. Preliminary clinical and laboratory experiences in children.
    Marget W; Adam D
    Acta Paediatr Scand; 1971 May; 60(3):341-5. PubMed ID: 5579860
    [No Abstract]   [Full Text] [Related]  

  • 5. Combined topical fluconazole and corticosteroid treatment for experimental Candida albicans keratomycosis.
    Schreiber W; Olbrisch A; Vorwerk CK; König W; Behrens-Baumann W
    Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2634-43. PubMed ID: 12766067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of efficacy of topical and oral fluconazole treatment in experimental Aspergillus keratitis.
    Avunduk AM; Beuerman RW; Warnel ED; Kaufman HE; Greer D
    Curr Eye Res; 2003 Feb; 26(2):113-7. PubMed ID: 12815530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical caspofungin for treatment of keratitis caused by Candida albicans in a rabbit model.
    Goldblum D; Frueh BE; Sarra GM; Katsoulis K; Zimmerli S
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1359-63. PubMed ID: 15793112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clotrimazole and bifonazole in the topical treatment of Candida keratitis in rabbits.
    Behrens-Baumann W; Klinge B; Uter W
    Mycoses; 1990; 33(11-12):567-73. PubMed ID: 2103595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Metastatic ophthalmia following candida septicemia. Experiences with the new oral antimycotic drug Bay b 5097].
    Freund J; Rüger K; Malchow H
    Klin Monbl Augenheilkd; 1972 Jul; 161(1):82-8. PubMed ID: 4539093
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of corticosteroids in antimycotic therapy of Candida keratitis].
    Behrens-Baumann W; Küster M
    Klin Monbl Augenheilkd; 1987 Sep; 191(3):222-5. PubMed ID: 3682686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experimental fungal keratitis due to Fusarium--the effects of topical antifungal agents-- (author's transl)].
    Ishibashi Y
    Nippon Ganka Gakkai Zasshi; 1978 Dec; 82(12):919-31. PubMed ID: 735970
    [No Abstract]   [Full Text] [Related]  

  • 12. [Successful treatment of candida sepsis with the oral antimycotic Bay b 5097].
    Malchow H; Seybold D; Lange H; Freund J; Rüger K
    Dtsch Med Wochenschr; 1972 Jun; 97(24):935-8. PubMed ID: 4503519
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of Candida pyuria with the oral antigungal drug Bay b 5097 (author's transl)].
    Exss R; Azubuike JC
    Padiatr Padol; 1973; 8(4):433-5. PubMed ID: 4583282
    [No Abstract]   [Full Text] [Related]  

  • 14. [A new antifungal agent for the treatment of systemic moniliasis following kidney transplantation].
    Wolf A; Pinggera WF; Stummvoll HK; Lobenwein-Weinegg E; Oppolzer R; Singer F
    Schweiz Med Wochenschr; 1973 Dec; 103(52):1883-6. PubMed ID: 4587171
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experience with the antimycotic agent BAY b 5097 in the local therapy of trichomonas vaginitis].
    Schnell JD
    Geburtshilfe Frauenheilkd; 1972 Sep; 32(9):787-90. PubMed ID: 5079033
    [No Abstract]   [Full Text] [Related]  

  • 16. Mycolase II: an enzyme antifungal agent interacts with the polyene antibiotic pimaricin in the treatment of keratomycosis.
    Oji EO
    Int Ophthalmol; 1982 Nov; 5(3):175-9. PubMed ID: 6984030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical fluconazole for experimental candida keratitis in rabbits.
    Behrens-Baumann W; Klinge B; Rüchel R
    Br J Ophthalmol; 1990 Jan; 74(1):40-2. PubMed ID: 2306443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies in experimental keratomycosis.
    O'Day DM
    Curr Eye Res; 1985 Mar; 4(3):243-52. PubMed ID: 4017624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of K-582, a new antifungal agent, on experimental Candida keratitis.
    Ohno S; Fuerst DJ; Okumoto M; Grabner G; Smolin G
    Invest Ophthalmol Vis Sci; 1983 Dec; 24(12):1626-9. PubMed ID: 6360948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy of combined vaginal infections with Trichomonas vaginalis and Blastomycetes. A controlled double-blind comparison of Metronidazole and Clotrimazole].
    Schnell JD; Rüther C
    Geburtshilfe Frauenheilkd; 1974 Jul; 34(7):551-7. PubMed ID: 4849985
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.